Search results
Results from the WOW.Com Content Network
Carl H. June (born 1953) is an American immunologist and oncologist. He is currently the Richard W. Vague Professor in Immunotherapy in the Department of Pathology and Laboratory Medicine at the Perelman School of Medicine of the University of Pennsylvania. [1]
He also co-hosted a medical education program for the Society for Immunotherapy of Cancer that discussed Advances in Cancer Immunotherapy on December 10, 2020. [ 66 ] Park has been chosen as a Castle Connolly Top Doctor [ 67 ] in Cancer by his physician peers in 2019, [ 68 ] 2020, [ 69 ] and 2021. [ 70 ]
The University of Illinois Hospital & Health Sciences System itself is composed of the 485-bed University of Illinois Hospital, outpatient diagnostic and specialty clinics, and two Federally Qualified Health Centers (FQHCs) that serve as primary teaching facilities for the University of Illinois Chicago (UIC) Health Science Colleges. The eight ...
Cancer immunotherapy (immuno-oncotherapy) is the stimulation of the immune system to treat cancer, improving the immune system's natural ability to fight the disease. [1] It is an application of the fundamental research of cancer immunology ( immuno-oncology ) and a growing subspecialty of oncology .
William Bradley Coley (January 12, 1862 – April 16, 1936) was an American bone surgeon and cancer researcher best known for his early contributions to the study of cancer immunotherapy, specifically causing infection as a way to fight cancer, a practice used as far back as 1550 BC. [1]
Immunotherapy or biological therapy is the treatment of disease by activating or suppressing the immune system. Immunotherapies designed to elicit or amplify an immune response are classified as activation immunotherapies, while immunotherapies that reduce or suppress are classified as suppression immunotherapies .
Steven A. Rosenberg (born 2 August 1940 [1]) is an American cancer researcher and surgeon, chief of Surgery at the National Cancer Institute in Bethesda, Maryland and a Professor of Surgery at the Uniformed Services University of Health Sciences and the George Washington University School of Medicine and Health Sciences.
James Allison, now at the University of Texas MD Anderson Cancer Center, was an early pioneer of immunotherapy. He discovered that CTLA-4 inhibits T cells from fully attacking, and hypothesized that blocking CTLA-4 could unleash the immune system to fight cancer. Initially, his idea was met with skepticism, but he continued his research and ...